Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's

Sonir R Antonini1, Valérie Baldacchino, Johanne Tremblay

  • 1Laboratory of Endocrine Pathophysiology, Research Centre, Hotel-Dieu du Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada.

Clinical Endocrinology
|January 13, 2006
PubMed
Abstract

Insights

Glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed in GIP-dependent Cushing's syndrome (CS). However, ACTH receptor (ACTHR) and downstream genes are suppressed, suggesting additional genetic events in CS pathogenesis.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • Ectopic expression of glucose-dependent insulinotropic polypeptide receptor (GIPR) in GIP-dependent Cushing's syndrome (CS) is not well understood.
  • The GIPR pathway is presumed to activate steroidogenesis via the Gs protein/cyclic AMP/protein kinase A (PKA) pathway, similar to the ACTH receptor (ACTHR).

Purpose of the Study:

  • To investigate the molecular mechanisms of GIPR ectopic expression and function in GIP-dependent CS.
  • To analyze the expression of genes in the Gs protein/cyclic AMP/PKA pathway within adrenal tissues of GIP-dependent CS patients.

Main Methods:

  • RNA extracted from adrenal tissues of nine GIP-dependent CS patients (seven AIMAH, two adenomas), controls, and Cushing's disease (CD) patients.
  • Multiplex RT-PCR used to evaluate expression of GIPR, ACTHR, SF-1, Nur77, DAX-1, CYP11A, 3beta-HSD, CYP21, CREB, and CREM genes.

Main Results:

  • GIPR mRNA was significantly overexpressed in all GIP-dependent CS cases.
  • ACTHR mRNA was detected in all GIP-dependent adrenal tissues.
  • Expression of steroidogenic enzymes and transcription factors in the ACTHR cascade was significantly reduced.

Conclusions:

  • GIPR is aberrantly expressed in GIP-dependent CS.
  • ACTHR and downstream genes, including steroidogenic enzymes and transcription factors, are suppressed in GIP-dependent CS.
  • Additional genetic events beyond aberrant receptor expression likely contribute to the altered ACTHR pathway activity in CS.

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...